Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner

Molecular Oncology

Volumn 8, Issue 1, 2014, Pages 50-58

  Põlajeva, Jelena ^a   Bergström, Tobias ^a   Edqvist, Per Henrik ^a   Lundequist, Anders ^b   Sjösten, Anna ^a   Nilsson, Gunnar ^c   Smits, Anja ^d   Bergqvist, Michael ^d   Pontén, Fredrik ^a   Westermark, Bengt ^a   Pejler, Gunnar ^b   Forsberg Nilsson, Karin ^a   Tchougounova, Elena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glioma; Mast cell; MIF; PSTAT5

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; NEUTRALIZING ANTIBODY; STAT5 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL INFILTRATION; CELL MIGRATION; CELLULAR SECRETION; CONTROLLED STUDY; CULTURE MEDIUM; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION;

BBB; BLOOD-BRAIN BARRIER; CBMC; CF; CI; CORD BLOOD MAST CELL; CYTOPLASMIC FRACTION; CYTOPLASMIC INTENSITY; GBM; GLIOBLASTOMA MULTIFORME; GLIOMA; IHC; IMMUNOHISTOCHEMISTRY; MAST CELL; MC; MICROPHAGE MIGRATION INHIBITORY FACTOR; MIF; PSTAT5; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; STAT; TISSUE MICROARRAY; TMA;

BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GLIOMA; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAST CELLS; STAT5 TRANSCRIPTION FACTOR;

EID: 84893008008     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.09.002     Document Type: Article

References (29)

1. Albesiano E., Han J.E., Lim M. Mechanisms of local immunoresistance in glioma. Neurosurg. Clin. N. Am. 2010, 21:17-29.
2. Anderson J.C., McFarland B.C., Gladson C.L. New molecular targets in angiogenic vessels of glioblastoma tumours. Expert. Rev. Mol. Med. 2008, 10:e23.
3. Bacher M., Schrader J., Thompson N., Kuschela K., Gemsa D., Waeber G., Schlegel J. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am. J. Pathol. 2003, 162:11-17.
4. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 2007, 13:587-596.
5. Conroy H., Mawhinney L., Donnelly S.C. Inflammation and cancer: macrophage migration inhibitory factor (MIF) - the potential missing link. QJM 2010, 103:831-836.
6. Elsir T., Qu M., Berntsson S.G., Orrego A., Olofsson T., Lindstrom M.S., Nister M., von Deimling A., Hartmann C., Ribom D., Smits A. PROX1 is a predictor of survival for gliomas WHO grade II. Br. J. Cancer 2011, 104:1747-1754.
7. Ferletta M., Caglayan D., Mokvist L., Jiang Y., Kastemar M., Uhrbom L., Westermark B. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. Int. J. Cancer 2011, 129:45-60.
8. Ferro E.A., Mineo J.R., Ietta F., Bechi N., Romagnoli R., Silva D.A., Sorda G., Bevilacqua E., Paulesu L.R. Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am. J. Pathol. 2008, 172:50-58.
9. Ghosh A., Chaudhuri S. Microglial action in glioma: a boon turns bane. Immunol. Lett. 2010, 131:3-9.
10. Hagerstrand D., Hesselager G., Achterberg S., Wickenberg Bolin U., Kowanetz M., Kastemar M., Heldin C.H., Isaksson A., Nister M., Ostman A. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene 2006, 25:4913-4922.
11. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
12. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006, 24:1030-1041.
13. Jensen B.M., Akin C., Gilfillan A.M. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br. J. Pharmacol. 2008, 154:1572-1582.
14. Kampf C., Olsson I., Ryberg U., Sjostedt E., Ponten F. Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas. J. Vis. Exp. 2012, 63.
15. Kim J.Y., Kwok S.K., Hur K.H., Kim H.J., Kim N.S., Yoo S.A., Kim W.U., Cho C.S. Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis. Clin. Exp. Immunol. 2008, 152:328-335.
16. Kirshenbaum A.S., Akin C., Wu Y., Rottem M., Goff J.P., Beaven M.A., Rao V.K., Metcalfe D.D. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk. Res. 2003, 27:677-682.
17. Kwiatkowska A., Symons M. Signaling determinants of glioma cell invasion. Adv. Exp. Med. Biol. 2013, 986:121-141.
18. Lindberg N., Kastemar M., Olofsson T., Smits A., Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 2009, 28:2266-2275.
19. Maltby S., Khazaie K., McNagny K.M. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim. Biophys. Acta 2009, 1796:19-26.
20. Mowafi F., Cagigi A., Matskova L., Bjork O., Chiodi F., Nilsson A. Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatr. Blood Cancer 2008, 50:812-817.
21. Nelson E.A., Walker S.R., Weisberg E., Bar-Natan M., Barrett R., Gashin L.B., Terrell S., Klitgaard J.L., Santo L., Addorio M.R., Ebert B.L., Griffin J.D., Frank D.A. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 2011, 117:3421-3429.
22. Pierau M., Na S.Y., Simma N., Lowinus T., Marx A., Schraven B., Bommhardt U.H. Constitutive Akt1 signals attenuate B-cell receptor signaling and proliferation, but enhance B-cell migration and effector function. Eur. J. Immunol. 2012, 42:3381-3393.
23. Polajeva J., Sjosten A.M., Lager N., Kastemar M., Waern I., Alafuzoff I., Smits A., Westermark B., Pejler G., Uhrbom L., Tchougounova E. Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS One 2011, 6:e25222.
24. Sjostrom M., Jakobsson P.J., Juremalm M., Ahmed A., Nilsson G., Macchia L., Haeggstrom J.Z. Human mast cells express two leukotriene C(4) synthase isoenzymes and the CysLT(1) receptor. Biochim. Biophys. Acta 2002, 1583:53-62.
25. Strouch M.J., Cheon E.C., Salabat M.R., Krantz S.B., Gounaris E., Melstrom L.G., Dangi-Garimella S., Wang E., Munshi H.G., Khazaie K., Bentrem D.J. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin. Cancer Res. 2010, 16:2257-2265.
26. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
27. Tran Thang N.N., Derouazi M., Philippin G., Arcidiaco S., Di Berardino-Besson W., Masson F., Hoepner S., Riccadonna C., Burkhardt K., Guha A., Dietrich P.Y., Walker P.R. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res. 2010, 70:4829-4839.
28. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., Zwahlen M., Kampf C., Wester K., Hober S., Wernerus H., Bjorling L., Ponten F. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 2010, 28:1248-1250.
29. Wang X.B., Tian X.Y., Li Y., Li B., Li Z. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. J. Neurooncol. 2012, 106:43-51.